May 10, 2022 / 07:00PM GMT
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst
I'm on the Bank of America Life Science Tools and Diagnostics team working with Derik De Bruin and covering the tech-enabled drug discovery space. And for our next session, we're excited to bring you Certara. We're joined by William Feehery, Chief Executive Officer; and Andrew Schemick, Chief Financial Officer. Gentlemen, thank you for coming out here.
William F. Feehery - Certara, Inc. - CEO & Director
Thank you.
Andrew Schemick - Certara, Inc. - CFO
Nice to be here, Ryskin.
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst
And format is going to be fireside chat, open and then we'll open up for Q&A towards the end of the presentation. So if you got any questions, feel free to jump in or just raise your hand throughout.
Certara Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers